J. Jordi Rowe
- Dermatology top 5%
- Cancer and Skin Lesions 6
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 12
- Lymphoma Diagnosis and Treatment 3
-
- Breast Cancer Treatment Studies 7
-
- HER2/EGFR in Cancer Research 3
-
- Soft tissue tumor case studies 5
-
- Salivary Gland Tumors Diagnosis and Treatment 4
-
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Chung‐Che ChangRichard A. PraysonErinn Downs‐KellyPhilip N. RedlichChristopher R. ChitambarAlison L. CheahBal KampalathBarbara Susnik
- Journals
- Journal of Clinical Oncology (1 paper)The American Journal of Surgical Pathology (1 paper)American Journal of Clinical Pathology (1 paper)
- Partner nations
- United StatesAustraliaSweden
In The Last Decade
J. Jordi Rowe
25 papers receiving 321 citations
Peers
Comparison fields: 5 of 50
- Dermatology 91
- Pathology and Forensic Medicine 178
- Cancer Research 107
- Oncology 103
- Genetics 22
Countries citing papers authored by J. Jordi Rowe
This map shows the geographic impact of J. Jordi Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jordi Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jordi Rowe more than expected).
Fields of papers citing papers by J. Jordi Rowe
This network shows the impact of papers produced by J. Jordi Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jordi Rowe. The network helps show where J. Jordi Rowe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Jordi Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 6 | |
| 7 | 2018 | 3 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 9 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 5 | |
| 13 | 2015 | 3 | |
| 14 | 2014 | 10 | |
| 15 | 2014 | 7 | |
| 16 | 2012 | 63 | |
| 17 | 2011 | 18 | |
| 18 | 2010 | 8 | |
| 19 | 2008 | 8 | |
| 20 | 2003 | 18 |
About J. Jordi Rowe
J. Jordi Rowe is a scholar working on Dermatology, Pathology and Forensic Medicine and Cancer Research, having authored 26 papers that have together received 324 indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (12 papers), Breast Cancer Treatment Studies (7 papers), Cancer and Skin Lesions (6 papers), Soft tissue tumor case studies (5 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Dermatology (91 citations), Pathology and Forensic Medicine (178 citations) and Cancer Research (107 citations). J. Jordi Rowe has collaborated with scholars based in United States, Australia and Sweden. Frequent co-authors include Chung‐Che Chang, Richard A. Prayson, Erinn Downs‐Kelly, Philip N. Redlich, Christopher R. Chitambar, Alison L. Cheah, Bal Kampalath, Barbara Susnik, Steven D. Billings and Thomas J. Lawton. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Surgical Pathology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.